• No results found

Development and validation of a Reverse Phase HPLC method for the determination of Rosiglitazone Maleate in tablet dosage form

N/A
N/A
Protected

Academic year: 2020

Share "Development and validation of a Reverse Phase HPLC method for the determination of Rosiglitazone Maleate in tablet dosage form"

Copied!
7
0
0

Loading.... (view fulltext now)

Full text

Loading

References

Related documents

The diagnosis can be suspected on newborn screening, but is established by demonstration of low plasma free carnitine concentration (<5 μ M, normal 25-50 μ M), reduced

The results of the microbiome analyses of datasets 1 and 2 are distinctly different, as the bacterial gen- era with the highest read numbers in datasets 1 and 2, especially in

Among the C1-INH-HAE patients, the carriers of the A3669G allele had significantly lower cortisol levels, and increased body mass index compared with non-carriers.. Conclusions:

This study aimed to develop and pilot test an educa- tional video containing information regarding the in- formed consent process for trauma patients undergoing surgery, develop

Patients with inflammatory bowel disease (IBD) may have increased risk of developing CDI, along with worse outcomes, higher rates of colectomy and higher rates of recurrence

Two of the four recognised species of the genus are infectious hae- matopoietic necrosis virus (IHNV), the aetiological agent of infectious haematopoietic necrosis (IHN), and

Figure 4.12 Simulation results for cycle II with hydrophobic carbon-based solid amine sorbent (HCBSA), in terms of water recovery (%), purity (%) in the heavy product at different